SARS-CoV-2 Monoclonal/Polyclonal Antibodies and Antigens developed nationally by TÜBİTAK MAM GMBE for Rapid Diagnosis Systems and ELISA kits are on sale.
Cytotoxicity, Sensitization and Irritation tests, as well as Genotoxicity test, which are the priority tests in the licensing of products, were ACCREDITED in 2021.
TR/V TÜBİTAK Marmara Research Vessel departs from İzmir Port for the first research expedition within the scope of the studies by the Turkish Earthquake Platform.
As a fruit of the cooperation between TÜBİTAK MAM Genetic Engineering and Biotechnology Institute and BİLGİ University Genetics and Bioengineering Department, a workshop was held on “Project Manage
